Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Patterson-UTI reports after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-22 | +$0.25 (+2.37%) | $0.37 (3.50%) | +$0.33 (+3.05%) | $1.35 (12.49%) |
| 2026-02-04 | +$0.14 (+1.79%) | $0.27 (3.46%) | +$0.22 (+2.77%) | $0.41 (5.16%) |
| 2025-10-22 | +$0.05 (+0.83%) | $0.23 (3.81%) | +$0.68 (+11.18%) | $0.47 (7.73%) |
| 2025-07-23 | +$0.31 (+5.29%) | $0.28 (4.78%) | -$0.07 (-1.13%) | $0.61 (9.81%) |
| 2025-02-05 | +$0.17 (+2.07%) | $0.25 (3.05%) | +$0.00 (+0.00%) | $0.58 (6.86%) |
| 2024-07-24 | N/A | N/A | N/A | N/A |
| 2024-05-01 | N/A | N/A | N/A | N/A |
| 2024-02-14 | N/A | N/A | N/A | N/A |
| Avg Abs Move | 2.47% | 3.72% | 3.63% | 8.41% |
Patterson-UTI has shown moderate volatility around earnings, with an average absolute Day 0 move of 2.47% and Day +1 move of 3.63%. The Day +1 reaction has been more pronounced, averaging an 8.41% intraday range as the market digests results.
The most significant post-earnings move came in October 2025, when the stock jumped 11.18% on Day +1 despite a modest 0.83% Day 0 move, suggesting the market took time to fully process the implications of that quarter's beat. More recently, the April 2026 report produced a 3.05% Day +1 gain with a 12.49% intraday range, reflecting heightened volatility as the company approached breakeven. Investors should expect meaningful price action in the session following this release, particularly given the binary nature of the profitability question.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 24) |
| Expected Move | $1.36 (11.14%) |
| Expected Range | $10.85 to $13.57 |
| Implied Volatility | 62.37% |
The options market is pricing an 11.14% expected move through the November 20 expiration, significantly higher than the stock's average historical Day +1 move of 3.63% and even exceeding the average Day +1 range of 8.41%. This elevated implied volatility suggests options traders are anticipating a larger-than-typical reaction to this earnings report, likely reflecting the high stakes around Patterson-UTI's return to profitability and the stock's 80%+ year-to-date rally.
Analysts maintain a Buy rating on Patterson-UTI with an average price target of $14.03, implying approximately 14.9% upside from the current price of $12.21. The consensus includes 7 Strong Buy ratings, 2 Moderate Buy ratings, and 6 Hold ratings, with no sell recommendations. Price targets range from a low of $12.00 to a high of $19.00.
Sentiment has deteriorated slightly over the past month, with the average recommendation slipping from 4.14 to 4.07 and one analyst downgrading from Hold to a more cautious stance. This modest cooling follows the stock's sharp year-to-date rally, with some analysts questioning whether the recovery is already reflected in the current valuation.
The consensus price target of $14.03 sits just above the stock's 52-week high territory, suggesting analysts see limited near-term upside beyond a successful earnings print. However, the wide range of targets—from $12.00 to $19.00—reflects divergent views on how quickly Patterson-UTI can convert operational improvements into sustained profitability and whether current drilling activity levels can support margin expansion through 2027.
Patterson-UTI enters earnings with strong technical momentum. The Barchart Technical Opinion stands at 80% Buy, up sharply from 56% Buy one week ago and 24% Buy one month ago, reflecting rapidly improving sentiment as the stock has rallied into the release.
Timeframe Analysis:
Trend Characteristics: The signal strength is rated as Average but is Strengthening, indicating momentum is building heading into the earnings release.
The stock is trading at $12.21, positioned above all key moving averages: the 5-day ($11.89), 10-day ($11.75), 20-day ($11.54), 50-day ($11.84), 100-day ($11.01), and 200-day ($10.48). This alignment of moving averages in bullish order provides strong technical support.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $11.89 | 50-Day MA | $11.84 |
| 10-Day MA | $11.75 | 100-Day MA | $11.01 |
| 20-Day MA | $11.54 | 200-Day MA | $10.48 |
The technical setup is supportive heading into earnings, with the stock holding above all major moving averages and showing strengthening momentum across timeframes. Key resistance sits near the $13.40 level—a decisive break of the 52-week high that would also clear the median analyst target. On the downside, the $11.84 50-day moving average represents the first meaningful support level, with a close below $11.40 potentially signaling a failed breakout. The stock's position above its 200-day moving average at $10.48 provides a longer-term technical floor, but the near-term risk/reward is asymmetric: confirmation requires an 11% move higher, while a technical breakdown sits just 5% below current levels.